Follow @ebcapital
Recent articles
Why Immunomedics Shares Surged 11.3% Today
Optimism is high that the company's lead pipeline candidate can secure an FDA OK.
Can Cannabis 2.0 Kickstart Marijuana Stocks?
Marijuana beverages, edibles, and vapes are finally available in Canada, but marijuana stocks still have big obstacles to overcome.
Here's Why uniQure Is Rallying 13% Today
Investor optimism is surging following recent M&A in gene therapy.
Here's Why ChemoCentryx Skyrocketed 278% Today
The company unveiled positive data for the most advanced drug in its pipeline.
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Why MacroGenics Stock Is Falling Today
Industry watchers are skeptical that the company's lead drug candidate can succeed.
Why SmileDirectClub Shares Soared 11.4% Today
Investors went bargain-hunting with the embattled marketer of teeth-alignment solutions.
Biogen's Alzheimer's Drug Goes From Bust to Boon, Plus Why Walgreens Is Shuttering 200 Healthcare Clinics
New data on Biogen's formerly shelved Alzheimer's disease drug puts it on a path toward blockbuster status, but it will have to win regulatory approval first.
3 Fast-Growing Medtech Stocks to Buy
Including one or more of these three top medical-device companies in your portfolio now could be savvy.
Why Aerie Pharmaceuticals Crashed 22.4% Today
Slow sales of its glaucoma drugs is forcing management to cut its sales guidance.
Why Insulet's Shares Rose 10.6% Higher Today
The maker of tubeless insulin pumps continues to deliver sales growth ahead of industry watchers' outlook.
Here's Why InMode Shares Are Jumping 18.5% Today
This fast-growing medical device company just reported better-than-expected results.
Pfizer Takes Aim at Regeneron, and UnitedHealth's Earnings Update
From small biotechs to big health insurance, and big pharma.
3 Beaten-Up Biotechs -- Are They Buys?
Is it finally time to add these three fallen biotech stocks to your portfolio?
Why OrganiGram Shares Tumbled 13.6% Today
Concerns over the pace of growth in cannabis sales are mounting.
How Amazon Is Shaking Up Telemedicine, Plus 1 Winner and 1 Loser Exiting ESMO
Seattle Genetics and Amgen are the stocks to watch following this year's European Society for Medical Oncology meeting.
Will Vaping Deaths Derail Marijuana Stocks? Plus, a New Treatment for Peanut Allergies Advances
How vaping risks may impact cannabis companies and Aimmune Therapeutics' plan to change how doctors treat peanut allergies.
3 Top Mid-Cap Stocks to Buy Right Now
Adding these growing mid-cap companies to portfolios this month could pay off.
How Doctors Treat Dementia and Lung Cancer Could Be About to Change
Patients have new hope following successful trials in dementia-related psychosis and lung cancer treatments.
Why Amgen's Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New Enemy
Amgen is acquiring Otezla, and The Medicines Company unveils stellar data for its cholesterol treatment.